Artemis Medicare Services Announces Final Dividend, Board Appointments, and FY26 Results
Artemis Medicare Services recommended a final dividend of ₹0.45 per share for FY26. The company approved its audited financial results for Q4FY26 and the full year. Mr. Tapan Mitra was appointed as an Independent Director, effective May 8, 2026, and Dr. Girdhar J. Gyani's appointment is proposed for August 1, 2026. M/s. T R Chadha & Co LLP was re-appointed as statutory auditors.
The dividend recommendation and financial results are material. The appointment of new directors and re-appointment of auditors are significant governance events that could impact investor confidence.
The announcement includes the recommendation of a final dividend and positive financial results, along with key board appointments and auditor re-appointment, indicating stable corporate governance and shareholder returns.
Artemis Medicare Services Limited announced the outcome of its Board Meeting held on May 8, 2026. The Board approved the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026.
Key decisions included the recommendation of a Final Dividend of ₹0.45 per Equity Share (45%) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting (AGM). The dividend will be paid within 30 days of the AGM's conclusion.
The Board also appointed Mr. Tapan Mitra as an Additional Director in the capacity of Independent Director for a period of 3 years, effective May 8, 2026. Shareholders' approval will be sought at the AGM for the appointment of Dr. Girdhar J. Gyani as an Independent Director for a period of 3 years, effective August 1, 2026. Additionally, the re-appointment of M/s. T R Chadha & Co LLP as Statutory Auditors for a second term of five years was approved, pending shareholder approval at the AGM.
The company also approved the extension of the period for utilization of unutilized funds from a preferential issue by 18 months. The Board meeting commenced at 4:00 PM and concluded at 5:50 PM.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.